| NEAGX | VSGIX | NEAGX / VSGIX | |
| Total Expense Ratio | 1.64 | 0.05 | 3,280% |
| Annual Report Gross Expense Ratio | 1.71 | 0.05 | 3,420% |
| Fund Existence | 25 years | 26 years | - |
| Gain YTD | 49.380 | 17.383 | 284% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.36B | 47B | 5% |
| Annual Yield % from dividends | 0.00 | 0.42 | - |
| Returns for 1 year | 66.13 | 26.88 | 246% |
| Returns for 3 years | 121.76 | 51.28 | 237% |
| Returns for 5 years | 131.43 | 27.73 | 474% |
| Returns for 10 years | 314.20 | 181.67 | 173% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MLPX | 75.81 | 1.18 | +1.58% |
| Global X MLP & Energy Infrastructure ETF | |||
| TEQI | 51.34 | 0.15 | +0.29% |
| T. Rowe Price Equity Income ETF | |||
| HYTI | 19.04 | 0.04 | +0.21% |
| FT Vest High Yield & Target Income ETF | |||
| IBBQ | 33.09 | N/A | N/A |
| Invesco Nasdaq Biotechnology ETF | |||
| VYLD | 29.74 | -0.16 | -0.52% |
| Inverse Vix Short-Term Futures Etns Due March 22, 2045 | |||